Cancer News and Research

Latest Cancer News and Research

Helix BioPharma closes private placement of 4,530,000 units

Helix BioPharma Corp. today announced that it has closed a private placement of 4,530,000 units at $2.43 per unit.

7 Aug 2010

Telik reports net loss of $4.9 million for second-quarter 2010

Telik, Inc. today reported a net loss of $4.9 million, or $0.09 per share, for the second quarter ended June 30, 2010, compared with a net loss of $5.7 million, or $0.11 per share, for the comparable period in 2009.

7 Aug 2010

Elekta receives Surescripts certification for MOSAIQ oncology information system

With health care providers' desire to increase accuracy, lower costs and increase efficiency, e-prescription use in the United States is exploding. Surescripts reports that by the end of 2009, approximately 18 percent of eligible prescriptions were prescribed electronically compared with just 6.6 percent at the end of 2008. And, the number of prescriptions routed electronically jumped from 68 million in 2008 to 191 million in 2009.

From Elekta 7 Aug 2010

SIRIUS XM Radio to broadcast call-in show for autism spectrum disorders

SIRIUS XM Radio today announced that in partnership with Autism Speaks it will broadcast Doctor Radio Reports: Understanding Autism - Looking for Answers, a live, two-hour call-in show hosted by veteran journalist Perri Peltz on which a panel of world-class doctors, experts, scientists and parents of affected children will explore the latest research and treatment options for autism and disorders on the autism spectrum and take calls from listeners across the country.

7 Aug 2010

Cyclacel second-quarter net loss decreases to $6.5 million

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the second quarter of 2010.

7 Aug 2010

Response Genetics total revenue for second-quarter 2010 increases 197% to $5.6 million

Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced its consolidated financial results for the three and six months ended June 30, 2010.

7 Aug 2010

Kids v Cancer applauds Senators for Creating Hope Act of 2010

Kids v Cancer applauds Senators Sam Brownback (R-KS), Sherrod Brown (D-OH), and Al Franken (D-MN) for their dedication to curing childhood diseases and supporting the bipartisan "Creating Hope Act of 2010."

7 Aug 2010

TrueBeam technology reduces cancer radiation treatment time

The Department of Radiation Oncology at the University of Alabama at Birmingham Comprehensive Cancer Center is among the world's first to begin using radiation technology that dramatically reduces treatment times.UAB's Hazelrig-Salter Radiation Oncology Center is the third U.S. site to acquire TrueBeam technology. TrueBeam, by Varian Medical Systems Inc., can complete a standard 40-minute radiation therapy in less than a minute for select patients. The precision of the instrument, measured in increments of less than a millimeter, comes from real-time patient imaging, positioning, beam shaping and many other data points synchronized continually as treatment progresses.

7 Aug 2010

Bradmer second-quarter net loss decreases to US$161,000

Bradmer Pharmaceuticals Inc. today announced its 2010 second quarter financial results.

7 Aug 2010

Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study

A newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana, but that is produced by the body's own nerve cells.

7 Aug 2010

Progenics announces EMA CHMP positive opinion for RELISTOR in pre-filled syringes

Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has issued a positive opinion for RELISTOR (methylnaltrexone bromide) subcutaneous injection in pre-filled syringes.

7 Aug 2010

Funk Out Cancer to raise money, awareness for research at University of Wisconsin

Funk Out Cancer is back for the second annual concert and silent auction to raise money and awareness for cancer research at the University of Wisconsin Carbone Cancer Center. Funk Out Cancer will feature music by international recording artists funk/jazz trio SOULIVE along with special guests Madison's own Phat Phunktion and Mama Digdown's Brass Band. The event will be held on Saturday, November 20 at 7:00 PM at the Orpheum Theatre, Madison.

7 Aug 2010

Surgery offers high survival rate for prostate cancer patients: Study

Surgery for localized prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study led by researchers at UCSF.The differences among therapies were more prominent at higher levels of cancer risk, and suggest, the researchers say, that in many cases surgery should play a greater role in treatment strategies for patients with prostate cancer that is likely to recur or spread.

7 Aug 2010

OncoGenex reports net income in second-quarter 2010 against loss last year

OncoGenex Pharmaceuticals, Inc. today reported unaudited financial results for the three and six months ended June 30, 2010 and reviewed the Company's highlights for the second quarter of 2010.

7 Aug 2010

BCF publishes two new patient publications

The Bone and Cancer Foundation is announcing the publishing of two new patient publications on Pain Management and Physical Therapy and other Rehabilitation Therapies. Other publication topics include: Breast Cancer, Prostate Cancer, Lung Cancer, Osteonecrosis of the Jaw, Vitamin D, Surgery, Myeloma and Osteosarcoma.

7 Aug 2010

S-ICD subcutaneous implantable defibrillator restores normal heartbeat in high risk cardiac arrest

Scottsdale Healthcare is the only Arizona hospital system testing a new under-the-skin device that uses an electrical shock to interrupt possibly fatal heart rhythms, restoring a normal heartbeat for patients at high risk of sudden cardiac arrest.The first Arizona patient received the device Thursday at Scottsdale Healthcare Shea Medical Center. Scottsdale Healthcare is the only Phoenix area hospital and one of only 35 in the world participating in the study.

7 Aug 2010

Research Roundups: Expanding Medicaid; More spending doesn't reduce mortality; Colonoscopy cost effectiveness; Kids, asthma and access to care

Health Affairs: Little Evidence Of Correlation Between Growth In Health Care Spending And Reduced Mortality - This study examines differences in hospital mortality and cost between 2000 and 2004 for patients at 122 U.S. hospitals, with seven common medical diagnoses: acute myocardial infarction, chronic obstructive pulmonary disease, community-acquired pneumonia, congestive heart failure, cerebrovascular accident (also called ischemic stroke), sepsis, or urinary tract infection.

7 Aug 2010

Scientists identify role of PNPASE in regulating RNA import into mitochondria

Researchers at UCLA's Jonsson Comprehensive Cancer Center and the departments of Chemistry and Biochemistry and Pathology and Laboratory Medicine have uncovered a role for an essential cell protein in shuttling RNA into the mitochondria, the energy-producing "power plant" of the cell. The import of nucleus-encoded small RNAs into mitochondria is essential for the replication, transcription and translation of the mitochondrial genome, but the mechanisms that deliver RNA into mitochondria remain poorly understood.

7 Aug 2010

Elsevier Properties congratulates Stewart for achieving Lectureship

Elsevier Properties SA is pleased to congratulate Dr. Scott Stewart on his winning the Royal Australian Chemical Institute's (RACI) 2010/11 Athel Beckwith Lectureship, sponsored by Reaxys.

6 Aug 2010

Norwegian cervical screening program begins reimbursing for liquid-based cytology

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that on July 1, 2010, the Norwegian cervical screening program began reimbursing for liquid-based cytology (LBC).

6 Aug 2010